prazosin has been researched along with Premature Birth in 1 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
Premature Birth: CHILDBIRTH before 37 weeks of PREGNANCY (259 days from the first day of the mother's last menstrual period, or 245 days after FERTILIZATION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Subjects were 11 patients who took prazosin during pregnancy and were counselled at the FRAME clinic in London Health Sciences Centre (Ontario, Canada) between 1 January 2000 and 31 December 2021." | 8.31 | Prospective evaluation of pregnancy outcomes after gestational exposure to prazosin. ( Campbell, MK; Garcia-Bournissen, F; Matsui, D; Zitoun, N, 2023) |
| "Subjects were 11 patients who took prazosin during pregnancy and were counselled at the FRAME clinic in London Health Sciences Centre (Ontario, Canada) between 1 January 2000 and 31 December 2021." | 4.31 | Prospective evaluation of pregnancy outcomes after gestational exposure to prazosin. ( Campbell, MK; Garcia-Bournissen, F; Matsui, D; Zitoun, N, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zitoun, N | 1 |
| Campbell, MK | 1 |
| Matsui, D | 1 |
| Garcia-Bournissen, F | 1 |
1 other study available for prazosin and Premature Birth
| Article | Year |
|---|---|
Prospective evaluation of pregnancy outcomes after gestational exposure to prazosin.
Topics: Female; Humans; Infant, Newborn; London; Ontario; Prazosin; Pregnancy; Pregnancy Outcome; Premature | 2023 |